Clinical trial
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With…
NCT00416832 · Christine Mauz-Körholz, Other · Completed
Key facts
| NCT number | NCT00416832 |
|---|---|
| Title | Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma |
| Official title | Optimising Therapy for Boys With Hodgkin's Lymphoma and Quality Assurance of Therapy for Girls With Hodgkin's Lymphoma Until Start of a New Prospective Trial for Hodgkin's Lymphoma in Childhood and Adolescence |
| Lead sponsor | Christine Mauz-Körholz, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Radiation |
| Interventions | cyclophosphamide, dacarbazine, doxorubicin hydrochloride, etoposide, prednisone, procarbazine hydrochloride, vincristine sulfate, radiation therapy |
| Enrollment | 648 |
| Start date | Nov 1, 2002 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Dec 28, 2006 |
| Last update posted | Mar 26, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: